- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Optum Declares HealthCare.gov Job Done
The contractor tapped to rescue the flailing HealthCare.gov in the fall of 2013 declared its work finished Thursday and said it doesn't plan to continue overseeing the website that sells subsidized insurance to millions of Americans as part of the federal health law.
The contractor tapped to rescue the flailing HealthCare.gov in the fall of 2013 declared its work finished Thursday and said it doesn’t plan to continue overseeing the website that sells subsidized insurance to millions of Americans as part of the federal health law.
UnitedHealth Group
.
“Having achieved the goal of making HealthCare.gov a stable and reliable platform for people seeking coverage, Optum will not rebid to continue the role of senior adviser,” said Matt Stearns, a spokesman for the company, the technology unit of insurer “Our job has been completed."
The company believes that relinquishing its HealthCare.gov role will have give it more freedom to pursue other contracts, said Mr Stearns. “By no longer acting as senior adviser to HealthCare.gov, Optum can seek to assist in other projects and leverage our ability to develop and operate large transactional systems that advance health care.”
Read more at Wall Street Journal: http://on.wsj.com/1EIH7CJ
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
